Standardizing blood thinner shots for heart patients
Part of Heart & circulation, Injuries & trauma, Pain clinical trials.
This study tests whether a standard way of giving blood thinner shots (LMWH) to people with heart disease in the cardiac care unit improves care. It is for Chinese patients who are awake and can make their own decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently in a heart unit (cardiac care unit) for a heart condition
- Your doctor has prescribed a blood thinner shot (LMWH) twice a day
- You are of Chinese ethnicity
- You are able to think clearly and make decisions for yourself
- You are awake and willing to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well certain blood thinners (NOACs and ticagrelor) work in Chinese patients and how they might affect bleeding risk. Researchers will measure drug levels and markers in your blood to try to make these medicines safer and more effective.
This study tests whether a lower dose of blood thinners can reduce bleeding problems while still preventing blood clots in people who have a HeartMate 3 heart pump. If you are stable on your current blood thinner, this trial might help you avoid serious bleeding complications.
This study tests a new medication called selatogrel in people with chronic coronary syndrome (long-term heart disease caused by narrowed heart arteries). Researchers want to see how the body processes this drug and whether it helps prevent future heart problems.
This study looks at how well blood thinners (anticoagulants) and inflammation markers work in people having heart or blood vessel procedures. It aims to better monitor these treatments to improve patient safety.
This study compares two doses of a blood thinner (enoxaparin) to see which better prevents blood clots in patients with severe injuries who are in the intensive care unit. It helps doctors choose the best dose to keep you safe and healthy.
This trial tests two blood thinner medicines, edoxaban and rivaroxaban, in Chinese patients with a blood clot in a brain vein (cerebral venous thrombosis). It aims to see if these medicines are safe and work well.
Hear when a new Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.